# Semaglutide (Wegovy) Treatment for Trichotillomania

> **NCT07282769** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Chicago** · enrollment: 10 (estimated)

## Conditions studied

- Trichotillomania (Hair-Pulling Disorder)
- Trichotillomania
- Hair Pulling Disorder
- Hair Pulling
- Hair-Pulling Disorder

## Interventions

- **DRUG:** Semaglutide

## Key facts

- **NCT ID:** NCT07282769
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07282769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07282769, "Semaglutide (Wegovy) Treatment for Trichotillomania". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07282769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
